Riskpilot← Back to searchSign inGet full accessOncolution AB
ABActiveOrg 5567063457Skogsfrugränd 14Research and experimental development on natural sciences and engineering · NACE 7210Est. 20060 employees
Revenue 2024
SEK 0
EBITDA margin
—
-15% vs 2023
Equity ratio
51.4%
Financial strength
Net profit 2024
SEK -20K
+8% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -100K | -15% |
| Net profit | SEK -20K | +8% |
| Total assets | SEK 9,9M | +10% |
| Equity | SEK 5,1M | +0% |
| Employees | 0 | — |
Legal name
Oncolution AB
Org number
5567063457
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
27 juni 2006
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet inom områdena Life Science och investeringsverksamhet inom samma område samt därmed förenlig verksamhet.
Address
Skogsfrugränd 14
Email
pollare@me.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2018 | 2019 | 2020 | 2021 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | −0 | −0 |
| EBITDA | −7 | 116 | 176 | −145 | −110 | −88 | −73 | −102 | −88 | −100 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — | — |
| EBIT | −7 | 116 | 176 | −145 | −110 | −88 | −73 | −102 | −88 | −100 |
| Net financials | 286 | −5 | 2 129 | −984 | −498 | 1 182 | 17 134 | −2 243 | −24 | −19 |
| Profit before tax | 216 | 77 | 2 221 | −472 | −350 | 958 | 16 518 | −955 | −22 | −20 |
| Tax | −42 | −22 | −56 | −12 | −0 | −88 | −336 | −0 | — | — |
| Net profit | 174 | 55 | 2 165 | −484 | −350 | 870 | 16 182 | −955 | −22 | −20 |
| Item | 2015 | 2016 | 2018 | 2019 | 2020 | 2021 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 5 419 | 5 909 | 8 193 | 7 469 | 7 715 | 8 774 | 25 872 | 9 326 | 9 012 | 9 937 |
| Equity | 5 169 | 5 224 | 7 389 | 6 905 | 6 555 | 7 425 | 23 607 | 5 152 | 5 130 | 5 110 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 090 | 4 115 |
| Short-term debt | 187 | 588 | 622 | 546 | 1 160 | 1 212 | 1 585 | 3 601 | 309 | 329 |
| Total debt | 187 | 588 | 622 | 546 | 1 160 | 1 212 | 1 585 | 3 601 | 3 399 | 4 444 |
EBITDA margin
-10049100.0%
This company
15.8%
Market median
-63601999% vs market
20152024
Equity ratio
51.4%
This company
38.2%
Market median
+35% vs market
20152024
Return on equity
-0.4%
This company
18.4%
Market median
-102% vs market
20152024
Net profit margin
-1996200.0%
This company
8.1%
Market median
-24644544% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
0.94×
This company
0.62×
Market median
+52% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-07-01 – 2021-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-01-01 – 2018-06-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TP Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
KH Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Oncolution AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Pollare | Chief Executive Officer | 0 companies |
| Karin Helene Andersson Viberg | Chief Auditor | 0 companies |
| Lena Elisabeth Pollare | Deputy Board Member | 0 companies |